A Prospective Active Surveillance Study to Monitor Growth, Development, and Maturation Among Adolescents with Atopic Dermatitis Exposed to Abrocitinib (B7451120)

14/04/2025
02/03/2026
EU PAS number:
EUPAS1000000515
Study
Ongoing
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

B7451120_ABROCITINIB INITIAL PROTOCOL_V1.0_19NOV2024.pdf

English (633.35 KB - PDF) View document
Study results
Study report
Study report

B7451120_ABROCITINIB PROGRESS REPORT 1_06FEB2026.pdf

English (2.16 MB - PDF) View document
Other information